Received 14.12.2022
DOI: 10.35556/idr-2023-2(103)16-20
Determination of the type of xerostomia in various somatic diseases
Mokhnacheva S.B., ORCID ID: 0000-0002-3133-0227, Karimova D.A., ORCID ID: 0000-0001-5318-8172
Federal State Budgetary Educational Institution of Higher Education “Izhevsk State Medical Academy” of the Ministry of Healthcare of the Russian Federation
Russia, 426034, Izhevsk, Kommunarov St., 281

E-mail address: svetlana-mokhnacheva@yandex.ru

Summary
The article presents the results of a comprehensive study of patients to determine the type of xerostomia (true or false xerostomia) in somatic diseases — diabetes mellitus, peptic ulcer disease, hypertension. Xerostomia and hyposalivation were detected in varying degrees in these diseases in patients with complaints of dry mouth. In diabetes mellitus dry mouth was observed in all patients, in peptic ulcer disease and hypertension the number of patients with complaints of xerostomia was almost 2 times less. Decreased salivation rate, significant increase in surface tension and viscosity of mixed saliva in diabetic patients created conditions for the development of sialostasis, which manifested as complaints of periodic tumescent pain, periodic inflammatory salivary glands.

Keywords: diabetes mellitus, peptic ulcer disease, hypertension, xerostomia, hyposalivation, surface tension, salivation rate, salivary acidity, salivary viscosity.

For citation: Mokhnacheva S.B., Karimova D.A. Determination of the type of xerostomia in various somatic diseases. Stomatology for All / Int. Dental Review. 2023, no.2(103): 16-20 (In Russian). doi: 10.35556/idr-2023-2(103)16-20

References
1. Brandini D.A., Takamiya A.S., Thakkar P., Schaller S., Rahat R., Naqvi A.R. Covid-19 and oral diseases: Crosstalk, synergy or association? Reviews Medical Virologi. 2021, 31(6): 22—26. doi: 10.1002/rmv.2226
2. Makedonova Yu.A. et al. Manifestation of diseases of the oral mucosa in patients with COVID-19. Bulletin of the Volgograd State Medical University. 2021, no.1(77): 110—115 (In Russian). doi: 10.19163/1994-9480-2021-1(77)-110-115
3. Gherlone E.F., Polizzi E., Tetè G., et al. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19. Journal of Dental Research. 2021, 100(5): 464—471. doi: 10.1177/0022034521997112
4 Khabadze Z.S., Sobolev K.E., Todua I.M., Mordanov O.S. Oral mucosal and global changes in COVID 19 (SARS-CoV-2): a single center descriptive study. Endodontics Today. 2020, 18(2): 4—9 (In Russian). doi: 10.36377/1683-2981-2020-18-2-4-9
5. Klein H., Asseo K., Karni N., Benjamini Y., Nir-Paz R., Muszkat M., Israel S., Niv M.Y. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. ClinMicrobiol Infect. 2021, 27(5): 769—774. doi: 10.1016/j.cmi.2021.02.008
6. Vaira L.A., Salzano G., Fois A.G., Piombino P., De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. International Forum Allergy Rhinology. 2020, 10(9): 1103—1104. doi: 10.1002/alr.22593
7. Sakalli E., Temirbekov D., Bayri E., Alis E.E., Erdurak S.C., Bayraktaroglu M. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients. Am J Otolaryngol. 2020, 41(6): 102622. doi: 10.1016/j.amjoto.2020.102622
8. Voitenkov V.B., Ekusheva E.V., Bedova M.A. Anosmia and ageusia in patients with COVID-19 infection. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2020, 26(3): 23—28 (In Russian). doi: 10.33848/foliorl23103825-2020-26-3-23-28
9. Glushchenko E.I., Symon A.M. The most likely causes of impaired smell and taste perception in COVID-19. University medicine of the Urals. 2020, no.7(24): 16—17 (In Russian). eLIBRARY ID: 45682996
10. Bigday E.V., Samoilov V.O. Olfactory dysfunction as an indicator of the early stage of COVID-19 disease. Integrative Physiology. 2020, no.1(3): 187—195 (In Russian). doi: 10.33910/2687-1270-2020-1-3-187-195
11. Hupsch-Marzec H., Dziedzic A., Skaba D., Tanasiewicz M. The spectrum of non-characteristic oral manifestations in COVID-19 — a scoping brief commentary. Medycyna Pracy. 2021, 72(6): 685—692. doi: 10.13075/mp.5893.01135
12. Egido-Moreno S., Valls-Roca-Umbert J., Jane-Salas E., Lopez-Lopez J., Estrugo-Devesa A. COVID19 and oral lesions, short communication and review. Journal of clinical and experimental dentistry. 2021, 13(3): 8. doi: 10.4317/jced.57981
13. Martin Carreras-Presas C., Amaro Sanchez J., Lopez-Sanchez A. F., Jane-Salas E., Somacarrera Pérez M.L. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral diseases. 2021, 27(3): 710—712. doi: 10.1111/odi.13382
14. Rusu L.C., Ardelean L.C., Tigmeanu C.V., Matichescu A., Sauciur I., Bratu E.A. COVID-19 and Its Repercussions on Oral Health: A Review. Medicina (Kaunas). 2021, 57(11): 11—89. doi: 10.3390/medicina57111189
15. Sinadinos A., Shelswell J. Oral ulceration and blistering in patients with COVID-19. Evidence Based Dentistry. 2020, 21(2): 49. doi: 10.1038/s41432-020-0100-z
16. Sulaymonova G.T., Shomuratova R.K., Akhmedova F.N. Characteristics of changes in the mucous membrane and microflora of the oral cavity during coronovirus infection. Science and education: problems and innovations. 2021: 153—159 (In Russian). eLIBRARY ID: 45682996
17. Toporkov A.V., Lipnitsky A.V., Polovets N.V., Viktorov D.V., Surkova R.S. Invasive mycoses-coinfections COVID-19. Article in the open archive. 2021, no.3111961: 4—6. (In Russian). https://covid19.neicon.ru/files/4028
18. Nuno Gonzalez A., Magaletskyy K., Martin Carrillo P., Lozano Masdemont B., Mayor Ibarguren A., Feito Rodriguez M., Herranz Pinto P. Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital. Actas Dermosifiliogr (Engl Ed). 2021, 112(7): 640—644. doi: 10.1016/j.ad.2021.02.007
19. Surboyo M.D., Ernawati D.S., Budi H.S. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection. Minerva Dent Oral Sci. 2021, 70(4): 161—168. doi: 10.23736/S2724-6329.21.04493-9